ArticleJournal for immunotherapy of cancer2026

Targeting CD6 in solid tumors: safety, early efficacy, and mechanistic insights from a proof-of-concept trial of itolizumab.

Cynthia González Muñoz et al.PubMed ↗Publisher ↗

No numbers read from the abstract.